Introduction {#sec1-1}
============

Diabetes mellitus (DM) was estimated to have affected 451 million people in 2017 worldwide, with a projection of 693 million by 2045.\[[@ref1]\] Diabetes affects over 34% of the Saudi population.\[[@ref2]\]

According to the World Health Organization (WHO), Saudi Arabia has the second-highest rate of diabetes in the Middle East and the seventh highest in the world with an expected population of 7 million living with diabetes and more than 3 million with prediabetes.\[[@ref3][@ref4]\] This presents an urgent and enormous public health issue.

Complementary medicine practices have numerous definitions. WHO defined the term traditional and complementary medicine (T and CM): "Traditional medicine is the total knowledge of health-related practices and skills based on indigenous beliefs and experiences," while "complementary medicine is the various health-related practices that are not part of that country\'s own tradition or conventional medicine."\[[@ref5]\]

Complementary therapies have been defined by the National Center for Complementary and Integrative Health (NCCIH) as "health approaches outside of the mainstream western medicine." As of lately, the NCCIH classified complementary medicine into three classifications: natural products, mind and body practices, and other complementary health approaches.\[[@ref6]\]

The utilization of T and CM among diabetic patients worldwide has been reported to be between 18% and 72.8%. Most utilized complementary therapies were herbs, dietary supplements, nutritional counseling, spiritual healing, and relaxation techniques.\[[@ref7]\]

There is insufficient data to determine the prevalence of complementary and alternative medicine (CAM) use among Saudi diabetic patients who live in Taif city. Information related to prevalence of CAM utilization, the causes and modes for use, and patient\'s disclosure of such use would help protect the health of patients, improve the patient-provider correspondence and coordination, and help incorporate CAM therapies into mainstream medicine.

Our study aimed to evaluate the magnitude and correlates of CAM use among diabetic patients attending diabetic clinics and primary healthcare in two government hospitals in Taif city, Saudi Arabia.

Methodology {#sec1-2}
===========

This is a descriptive cross-sectional investigation conducted between February and June 2019 on diabetic patients attending primary health clinics of National Guards and Military Hospitals in Taif, Saudi Arabia. Systematic random sampling was used for recruiting adult diabetic patients, waiting for their turn to be seen by their family physician, on randomly selected days.

The survey questionnaire was carefully designed by the research team that included nursing staff, family physician, and diabetologist. The content validity of the questionnaire was confirmed by an expert panel of a physician. The original version of the questionnaire was written in English and subsequently translated to Arabic (since all of the patients spoke Arabic). The translated Arabic version was back-translated by a professional translator to ensure the parallel-form reliability of the questionnaire, to the grantee that all questions were properly translated, and to check the translation quality. The original and back-translated version was reviewed for consistency in meaning by two bilingual experts. A pilot study was conducted with 15 selected diabetic patients to ensure that the target population understood the questions and that the answers yielded the required data. Questionnaires were filled out through a face-to-face interview taking an average of 5--10 min to complete. Weekly meetings of the research team were held to ensure inter-rater reliability and adherence to data collection protocol.

The data were checked for completeness, and responses were coded and entered into the statistical package for the social sciences (SPSS) software version 25 for windows. Frequencies and percentages were used to assess the qualitative variable (the prevalence, types, mode, and patterns of CAM). Chi-square and Mann-Whitney tests were used to chart comparisons of categorical and continuous variables between users and nonusers of CAM. The binary logistic regression analysis was used to analyze the independent predictors with its odds ratios for our binary outcome. The statistical significance was considered with a *P* value of \<0.05.

Ethical approval was granted from the Regional Research and Ethics Committee in Taif and Alhada Armed Hospitals. The approval was granted on February 1^st^, 2019.

Results {#sec1-3}
=======

In the present study, 54.6% constituted females. As per [Table 1](#T1){ref-type="table"}, the mean age of the participants was (60.37 ± 12.25 years), most of them were not educated (37.4%), not working (52.9%), married (98%), and most of them (62%) had an income less than 5000 INR. All the studied patients were of type 2 diabetes.

###### 

Descriptive data of the participants

  Variable                           No. (%)
  ---------------------------------- -------------
  Age (Mean±SD)                      60.37±12.25
  Gender                             
   Male                              159 (45.4)
   Female                            191 (54.6)
  Education                          
   Not educated                      131 (37.4)
   Basic (primary and preparatory)   97 (27.7)
   Secondary                         19 (5.4)
   University and higher             103 (29.4)
  Occupation                         
   Not working                       185 (52.9)
   Military                          19 (5.4)
   Retired                           118 (33.7)
   Employee                          18 (5.1)
   Others                            10 (2.9)
  Income                             
   \<5000 INR                        217 (62)
   5000 \<10000 INR                  98 (25.4)
   10000 \<15000 INR                 32 (9.1)
   15000 INR and above               12 (3.4)
  Marital status                     
   Married                           343 (98)
   Unmarried                         7 (2)

Moreover, [Table 2](#T2){ref-type="table"} demonstrates that the mean age at diagnosis of diabetes among the participants was (45.6 ± 13.3 years), with 56% of the participants had a comorbid chronic disease. Around 39.7% had diabetes for 9 to 12 years, 66.3% had an FH of diabetes, and 40.6% were on both insulin and oral hypoglycemic pills for diabetes control. Of the participants, 58% had at least one diabetic complications (of them, the most common was the eye complications).

###### 

Clinical character of diabetes among studied patients (No: 350)

  Variable                                       No. (%)
  ---------------------------------------------- ------------
  Age at diagnosis (Mean±SD)                     45.6±13.36
  Presence of another chronic disease            
   Yes                                           196 (56)
   No                                            154 (44)
  Duration of diabetes less than 3 years         
  less than 3 years                              79 (22.6)
   3-less than 6                                 73 (20.9)
   6-less than 9                                 45 (12.9)
   9-less than 12                                139 (39.7)
   12 and more                                   14 (4)
  Presence of FH of diabetes                     
   Yes                                           232 (66.3)
   No                                            118 (33.7)
  Diabetes medication used                       
   Insulin                                       64 (18.3)
   Oral hypoglycemic pills                       67 (19.1)
   Diet and exercise                             1 (0.3)
   Both insulin and oral hypoglycemic pills      142 (40.6)
   Oral hypoglycemic pills, diet, and exercise   76 (21.7)
  Having at least one                            
   Yes                                           203 (58)
   No                                            147 (42)
   Kidney complications                          56 (16)
   Heart complications                           34 (9.7)
   Brain complications                           5 (1.4)
   Eye complications                             172 (49.1)

As for CAM use, the prevalence was 33.7% with 87.3%, not consulting doctor prior to CAM use. CAM use was mostly for over 1 year, with 43.2% having more than one source of information regarding herbal medicines. As for the reason for CAM use, 58.5% reported believing in their advantages \[[Table 3](#T3){ref-type="table"}\].

###### 

Prevalence of CAM use, consulting a doctor before use, duration of its usage, source of information about herbal medicine, and why using the CAM among the studied CAM users participants (No: 118)

  Variable                                           No. (%)
  -------------------------------------------------- ------------
  CAM use                                            
   Yes                                               118 (33.7)
   No                                                232 (66.3)
  Consulted a doctor before using CAM                
   Yes                                               15 (12.7)
   No                                                103 (87.3)
  Duration of CAM use                                
   1-7 days                                          5 (4.2)
   2-4 weeks                                         11 (9.3)
   1-12 months                                       20 (16.9)
   \>1 year                                          (69.5)
  Source of information regarding herbal medicines   
   Friends, relatives, neighbors                     34 (28.8)
   Internet                                          4 (3.4)
   Personal choice                                   5 (4.2)
   Media                                             6 (5.1)
   Family believes.                                  15 (12.7)
   Health practitioner                               3 (2.5)
   More than one answer                              51 (43.2)
  Why using CAM                                      
   Believe in the advantages of CAM practices        69 (58.5)
   Lost hope with conventional therapy               3 (2.5)
   looking for another solution                      15 (12.7)
   CAM is accessible and available                   12 (10.2)
   More than one answer                              19 (16.1)

The mean cost of the CAM was (44.58 ± 64.25 SAR). Around 25.4% of participants expected lowering blood glucose level but 20.3% reported that they felt no change after their use. However, 49.2% of the sample reported that CAM was very useful, and 72.9% did not notice any side effect from CAM use, 49.2% were willing to reuse the CAM in the future, and 47.5% recommended CAM to fellow diabetic patients \[[Table 4](#T4){ref-type="table"}\].

###### 

Experience of CAM use among studied CAM users (No: 118)

  Variable                                                 No. (%)
  -------------------------------------------------------- -------------------
  Your expectation when you were using CAM                 
   Complete cure of disease Lowering blood glucose level   3 (2.5) 30 (25.4)
   Better health status                                    12 (10.2)
   Prevent progression of diabetes                         4 (3.4)
   Weight loss                                             1 (0.8)
   More than one answer                                    60 (50.8)
   No expectations.                                        8 (6.8)
  Your feeling after CAM use                               
   A feeling of strengthening of the body                  19 (16.1)
   A feeling of the disappearance of several symptoms      12 (10.2)
   A feeling of being in a good psychological condition    21 (17.8)
   Improvement of sexual life                              1 (0.8)
   A feeling of no change                                  24 (20.3)
   A feeling of being in the bad psychological condition   1 (0.8)
   Feeling rise of several symptoms                        1 (0.8)
   More than one answer                                    32 (27.1)
   Not decided.                                            7 (5.9)
  How you assess the usefulness of CAM                     
   Very useful                                             58 (49.2)
   Not sure/unable to assess.                              19 (16.1)
   Of limited usefulness                                   34 (28.8)
   Not useful at all.                                      7 (5.9)
  Noticed any side effect from using CAM                   
   Yes                                                     11 (9.3)
   No                                                      86 (72.9)
   Undecided                                               21 (17.8)
  Using CAM again in the future                            
   Yes                                                     58 (49.2)
   No                                                      22 (18.6)
   Undecided                                               38 (32.3)
  Recommended CAM to other DM patients Yes                 56 (47.5)
   No                                                      22 (18.6)
   Undecided                                               39 (33.9)
  Cost of CAM used (Mean±SD)                               44.58±64.25

Among patients surveyed, 62.7% used more than one CAM, 100% used bitter apple, 66.1% took cinnamon, 55.1% consumed ginger, 35.6% had fenugreek, and 21.2% reported using garlic as an only CAM. The rest of the CAM was used under 20% of the participants \[[Table 5](#T5){ref-type="table"}\].

###### 

Detailed distribution of the CAM used among studied patients (No: 118)

  Variable               No. (%)       Variable                No. (%)
  ---------------------- ------------- ----------------------- ------------
  Ginger                               Clove                   
   Yes                   65 (55.1)      Yes                    14 (15.9)
   No                    53 (44.9)      No                     104 (88.1)
  Black seeds                          White lupin             
   Yes                   26 (22)        Yes                    1 (0.8)
   No                    92 (78)        No                     117 (99.2)
  Cinnamon                             Vitamins and minerals   
   Yes                   78 (66.1)      Yes                    10 (8.5)
   No                    40 (33.9)      No                     108 (91.5)
  Fenugreek                            Rosemary                
   Yes                   42 (35.6)      Yes                    4 (3.4)
   No                    76 (64.4)      No                     114 (96.6)
  Garlic                               Pomegranate             
   Yes                   25 (21.2)      Yes                    5 (4.2)
   No                    93 (78.8)      No                     113 (95.8)
  Myrrh                                Olive leaves.           
   Yes                   19 (6.1)       Yes                    5 (4.2)
   No                    99 (83.9)      No                     113 (95.8)
  Aloes                                Bitter apple            
   Yes                   4 (3.4)        Yes                    118 (100)
   No                    114 (96.6)     No                     0 (0.0.0)
  Neem                                 Radish                  
   Yes                   1 (0.8)        Yes                    3 (2.5)
   No                    117 (99.2)     No                     115 (97.5)
  Honey                                Garden cress.           
   Yes                   23 (19.5)      Yes                    17 (14.4)
   No                    95 (80.5) 1    No                     101 (85.6)
  Wormwood                             Arabic gum.             
   Yes                   13 (11)        Yes                    6 (5.1)
   No                    105 (89)       No                     112 (94.9)
  Barely                               Helteet                 
   Yes                   18 (15.3)      Yes                    4 (3.4)
   No                    100 (84.7)     No                     114 (96.6)
  Spiritual (ruqia)                                            
   Yes                   15 (12.7)                             
   No                    103 (87.3)                            
  More than one answer                                         
   Yes                   74 (62.7)                             
   No                    44 (37.3)                             

As for the CAM nonusers, 16.4% reported that their cause was not the prescription by the doctor. Whereas 84.1% of them were not willing to use CAM in the future \[[Table 6](#T6){ref-type="table"}\]. Female patients were more likely to use CAM compared to males (41.9% vs. 23.9%) (*P* = \<0.05). While the association between CAM use and other sociodemographic characteristics was not significant (age, education, occupation, income, comorbid illness, or marital status) (*P* =\>0.05) \[[Table 7](#T7){ref-type="table"}\].

###### 

Attitude of CAM nonuser participants towards CAM use (No: 232)

  Variable                              No. (%)
  ------------------------------------- ------------
  Reasons for not using CAM             
   The doctor did not prescribe it      38 (16.4)
   Afraid of the side effects           20 (8.6)
   Mainstream medicine is the best      5 (2.2)
   Additional expenses and useless      1 (0.4)
   Do not believe it                    11 (4.7)
   Do not need it                       10 (4.3)
   Never heard of it                    8 (3.4)
   Not interested                       9 (3.9)
   No one advised its use               6 (2.6)
   More than one answer                 122 (53)
  Considering using CAM in the future   
   Yes                                  37 (15.9)
   No                                   195 (84.1)

###### 

Relationship between CAM use and sociodemographic characters of studied participants (No.:118)

  --------------------------------------------------------------------------------------
  Variable                           Using CAM\   Not using CAM\   Test        *P*
                                     No. (%)      No. (%)                      
  ---------------------------------- ------------ ---------------- ----------- ---------
  Age (Mean±SD)                      59.8±12.19   60.66±12.29      1.01\*      0.31

  Gender                                                                       

   Male                              38 (23.9)    121 (78.1)       12.55\*\*   \<0.001

   Female                            80 (41.9)    111 (58.1)                   

  Education                                                                    

   Not educated                      51 (58.9)    80 (61.1)        5.53\*\*    0.14

   Basic (primary and preparatory)   24 (24.7)    73 (75.3)                    

   Secondary                         6 (31.6)     13 (68.4)                    

   University and higher             37 (35.9)    66 (64.1)                    

  Occupation                                                                   

   Not working                       75 (40.5)    110 (59.5)       9.19\*\*    0.05

   Military                          5 (26.3)     14 (73.7)                    

   Retired                           29 (24.6)    89 (75.4)                    

   Employee                          5 (27.8)     13 (72.2)                    

   Others                            4 (40)       6 (60)                       

  Income                                                                       

   \<5000 INR                        77 (35.5)    140 (64.5)       2           0.57

   5000 \<10000 INR                  29 (32.6)    60 (67.4)                    

   10000 \<15000 INR                 10 (31.3)    22 (68.8)                    

   15000 INR and above               2 (16.7)     10 (83.3)                    

  Marital status                                                               

   Married                           114 (33.2)   229 (66.8)       1.75\*\*    0.18

   Unmarriedd                        4 (57.1)     3 (42.9)                     
  --------------------------------------------------------------------------------------

\*U=Mann-Whitney test. \*\* χ^2^=Chi-square test

CAM use was higher when family history of diabetes was present (38.8% vs. 23.7%) (*P* = \<0.05), see \[[Table 8](#T8){ref-type="table"}\]. Participants with longer duration of diabetes, and those with at least one diabetic complication were more likely to use CAM (*P* = \< 0.05). When adjusting for clinical and sociodemographic factors simultaneously, as per \[[Table 9](#T9){ref-type="table"}\] female gender, duration of diabetes, and having at least one diabetic complication were independent predictors for CAM use.

###### 

Relationship between CAM use and clinical character of diabetes among studied participants (No: 118)

  ----------------------------------------------------------------------------------------------
  Variable                                     Using CAM\   Not using CAM\   Test        *P*
                                               No. (%)      No. (%)                      
  -------------------------------------------- ------------ ---------------- ----------- -------
  Age at diagnosis (Mean±SD)                   43.6±14.68   46.61±12.55      1.62\*      0.1

  Presence of another chronic disease                                                    

   Yes                                         67 (34.2)    129 (65.8)       0.04\*\*    0.83

   No                                          51 (33.1)    103 (66.9)                   

  Duration of diabetes                                                                   

   less than 3 years                           22 (27.8)    57 (72.2)        18.29\*\*   0.001

   3-less than 6                               17 (23.3)    56 (76.7)                    

   6-less than 9                               16 (35.6)    29 (64.4)                    

   9-less than 12                              52 (37.4)    87 (62.6)                    

   12 and more                                 11 (78.6)    3 (21.4)                     

  Presence of FH of diabetes                                                             

   Yes                                         90 (38.8)    142 (61.2)       7.94\*\*    0.005

   No                                          28 (23.7)    90 (76.3)                    

  Having at least one diabetic complications                                             

   Yes                                         82 (40.4)    121 (59.6)       9.65\*\*    0.002

   No                                          36 (24.5)    111 (75.5)                   
  ----------------------------------------------------------------------------------------------

\*U=Mann-Whitney test. \*\* χ^2^=Chi-square test. \*\* χ^2^=Chi-square test

###### 

Binary logistic regression analysis regarding the risk factors for CAM use among studied participants

  Variable                                     CAM use   Significance          
  -------------------------------------------- --------- -------------- ------ ---------
  Gender                                       0.87      12.75          0.41   \<0.001
  Duration of diabetes                         0.22      5.15           0.8    0.02
  Presence of FH of diabetes                   0.7       7.44           2.06   0.006
  Having at least one diabetic complications   0.51      4.03           1.67   0.04

Discussion {#sec1-4}
==========

In our current study, both sociodemographic and clinical characteristics of participants were comparable to findings from previous regional surveys, particularly in terms of female predominance,\[[@ref8]\] rate and nature of diabetes complications and comorbidities,\[[@ref9][@ref10]\] onset age,\[[@ref11]\] and family history.\[[@ref12]\]

One key finding in our present study is the prevalence of 33.7% of CAM use among diabetes clinics\' attendees in Taif city. This is clearly consistent with the rates (32.18%) and (30.5%) of herbal medicines\' use reported in Riyadh, Saudi Arabia in 2018 and 2016, respectively.\[[@ref6][@ref13]\] In Taif, a similar investigation reported 24.6% prevalence of herbs use among diabetic subjects\[[@ref14]\] whereas in Mecca, a rate of 30.1% was uncovered.\[[@ref15]\] Similarly, our results agree with the overall (36.95%) prevalence of CAM uptake among Saudi general public.\[[@ref16]\]

However, rates of CAM use in Saudi Arabia, as confirmed by our current results, fall below the rates reported internationally in India,\[[@ref17]\] Malaysia,\[[@ref18]\] Bahrain,\[[@ref19]\] Oman\[[@ref19]\] and Lebanon.\[[@ref20]\] It may be difficult to explain variations in herbal medicine uptake across different countries. Differences in sociocultural perceptions of CAM use, their availability, their accessibility, in addition to differences in study design, and CAM definition could have all contributed to differences in prevalence rates reported in different studies.

The striking results of our survey are the strong belief by people in Taif region that CAM is very advantageous. This belief, in addition to accessibility and lower cost of CAM, may have contributed to the increased rate of CAM use in our study sample.

Furthermore, we found that spiritual healing was used by a significant proportion of T2DM patients (12.7%). A previous cross-sectional study in Riyadh city found that 10.8% of diabetic participants were using spiritual healing (ruqia).\[[@ref13]\]

CAM has wide acceptance in the Saudi population. This might be explained by strong religious views that many of the patients base their CAM use on, and possibly lack of awareness regarding the potential for serious side effects and complications. People also are unaware of the poor evidence that supports CAM use. Being illiterate and born in a village were found to bear a significant association with CAM use in Saudi Arabia.\[[@ref21]\]

In agreement with previous studies, we found only a worrying minority of 12.7% who consulted a doctor before using CAM.\[[@ref15][@ref22][@ref23]\] This result reinforces how inadequate doctor-patient (and pharmacist-patient) relationship leads to concealment of CAM use. In Taif, CAM is often recommended by friends and peers who provide information regarding the benefit of CAM use in exclusion of physicians and pharmacists.\[[@ref14]\] Routine inquiry about CAM use should be adopted in clinical encounters, given the popularity of this practice.

Indicative of a high level of satisfaction with CAM use, 47.5% of our sample would recommend their use. Such a trend was established across international studies.\[[@ref16][@ref17]\] Some 58.5% of our participants believed in a positive effect for CAM, with only 9.3% attributed any adverse effect to CAM. This is also a consistent finding in many global surveys of CAM-related behaviors and attitudes.\[[@ref24][@ref25]\] Qualitative studies with comprehensive thematic analysis are required to further understand the underpinning concepts of such beliefs.

Female patients and those with a positive family history of complications of diabetes, in the sample we surveyed, were more likely to use CAM, as established in many other studies.\[[@ref26][@ref27]\] Clearly, the use of CAM by a family member or perception of conventionally untreated complication could pressurize patients in seeking help from CAM. Affordability of CAM was also established to motivate their use.\[[@ref28]\] T2DM,\[[@ref29]\] lower education,\[[@ref24]\] and female gender\[[@ref30]\] were established factors associated with CAM use. The findings from our investigation certainly confirm such an association in Saudi society.

Bitter apple, cinnamon, and ginger were the most used CAM methods among our participants. In his earlier survey, Al-Rowais found patients using mainly myrrh (*Commiphora molmol*), black seeds (*Nigella sativa*), fenugreek (*Trigonella foenum-graecum*), helteet (*Ferula assa-foetida*), and aloes (*Aloe vera*).\[[@ref22]\] Same herbs were found in use in more recent investigations in addition to Neem (*Azadirachta indica*), abundant in Mecca Province.\[[@ref15][@ref31][@ref32]\]

Family physicians often encounter patients who declare usage of complementary medicinal herbs. It is established that primary care physicians hold fluid and variable views towards alternative medicines use.\[[@ref33]\] The need for information about the scale of the issue of CAM use is pressing indeed.

The current study adds to the present evidence regarding the prevalent use of CAM among diabetic patients. It has many strengths including large sample size and use of a comprehensive questionnaire. However, one limitation should be allowed before generalizing its results. Social desirability and recall bias may have underestimated the overall CAM prevalence, and future research may have to be community-based rather than hospital-based.

Conclusion {#sec1-5}
==========

The use of CAM therapies among T2DM patients in Taif is prevalent. Hence, decision-makers should consider the potential risks and benefits of CAM therapies. A concerted effort by the government, orders and syndicates, medical, nursing and health schools, and educational institutions is required to enhance education about the safe use of CAM and sharing their use with their family physician should be encouraged with all diabetic patients. Future studies should be large-scale, community-based to validate the findings of this current investigation.
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